Diastolic dysfunction and high levels of new cardiac biomarkers as risk factors for cardiovascular events and mortality in hemodialysis patients

Blood Purification

Volumn 36, Issue 2, 2013, Pages 98-106

  Quiroga, Borja ^a   Villaverde, Maite ^b   Abad, Soraya ^a   Vega, Almudena ^a   Reque, Javier ^a   López Gómez, Juan M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Hemodialysis Unit   (Spain)

Author keywords

Cardiovascular events; Diastolic dysfunction; Hemodialysis; Mortality; Nt proBNP; Troponin

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84889643661     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000354080     Document Type: Article

References (41)

1. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, Luley C: Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 17: 1964-1969.
2. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patient. Kidney Int 1999; 55: 648-658.
3. Nicholas SB: Cardiac biomarkers and prediction of ESRD. Am J Kidney Dis 2011; 58: 689-691.
4. Dinh W, Nickl W, Futh R, Lankisch M, Hess G, Zdunek D, Scheffold T, Barroso MC, Tiroch K, Ziegler D, Seyfarth M: High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study. BMC Cardiovasc Disord 2011; 5:11-41.
5. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Calonge VM, Moatti N, Buisson C, Jacquot C: Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis 2003; 42: 513-523.
6. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, Koerbin G, Southcott E, Potter JM: Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009; 39: 812-818.
7. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A: Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease. A metaanalysis. Circulation 2005; 112: 3088-3096.
8. Mockel M, Schindler R, Knorr L, Muller C, Heller G Jr, Stork TV, Frei U: Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant 1999; 14: 1489-1495.
9. Musso P, Cox I, Vidano E, Zambon D, Panteghini M: Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance. Clin Biochem 1999; 32: 125-130.
10. Kavsak PA, MacRae AR, Yerna MJ, Jaffe AS: Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009; 55: 573-577.
11. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858-867.
12. Dounaevskaia V, Yan AT, Charytan D, DiMeglio L, Leong-Poi H, Al-Hesayen A, Goldstein MB, Wald R: The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease. J Nephrol 2011; 24: 41-49.
13. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol 2009; 4: 1925-1931.
14. Foley RN, Curtis BM, Randell EW, Parfrey PS: Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010; 5: 805-813.
15. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-1285.
16. Pecoits-Filho R, Bucharles S, Barberato SH: Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial 2012; 25: 35-41.
17. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
18. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2: 89-99.
19. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277.
20. Madziarska K, Weyde W, Gosek K, Kopec W, Penar J, Klak R, Zukowska-Szczechowska E, Krajewska M, Kusztal M, Golebiowski T, Radziszewska D, Klinger M: Serum levels of proANP and albumin are independent predictors of mortality in the high-risk patients (elderly and diabetics) treated by haemodialysis and continuous peritoneal dialysis in 4-year prospective observation. Nephrol Dial Transplant 2010; 25: 3800-3801.
21. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P: Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis 1995; 26: 209-219.
22. Rosenberger EL, Goff DC Jr, Davis CC, Blackwell CS, Bertoni AG: Control of blood pressure in North Carolina primary care: baseline data from the GLAD Heart Trial. NC Med J 2008; 69: 441-446.
23. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program. Bethesda, National Heart, Lung, and Blood Institute, 2004.
24. Maduell F, Garcia M, Alcazar R; Sociedad Espanola de Nefrologia (SEN): Dosage and adaptation of dialytic treatment. Hemodialysis centers guides. Nefrologia 2006; 26(suppl 8):15-21.
25. Devereux RB, Savage DD, Drayer JI, Laragh JH: Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension 1982; 4: 524-531.
26. US Renal Data System: USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2004.
27. Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A: Comparison of serum albumin, Creactive protein and carotid atherosclerosis as predictors of 10-year mortality hemodialysis patients. Hemodial Int 2010; 14: 226-232.
28. Dumler F: Hypoalbuminemia is a marker of overhydration in chronic maintenance patients on dialysis. ASAIO J 2003; 49: 282-286.
29. Barberato SH, Bucharles SG, Sousa AM, Costantini CO, Costantini CR, Pecoits-Filho R: Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis. Arq Bras Cardiol 2012; 94: 457-462.
30. Takahashi A, Takase H, Toriyama T, Sugiura T, Kurita Y, Ueda R, Dohi Y: Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant 2006; 21: 2507-2512.
31. Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U: Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J Nephrol 2006; 19: 77-83.
32. Di Iorio BR, Bellizzi V, Cillo N, Cirillo M, Avella F, Andreucci VE, De Santo NG: Vascular access for hemodialysis: the impact on morbidity and mortality. J Nephrol 2004; 17: 19-25.
33. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J; CHOICE Study: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-1455.
34. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT: Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68: 818-825.
35. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman JP, van Dieijen-Visser MP: Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-3096.
36. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, Kooman JP, van Dieijen-Visser MP: Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009; 46: 283-290.
37. Wang AY, Lam CW, Wang M, Chan IH, Goggins WB, Yu CM, Lui SF, Sanderson JE: Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem 2007; 53: 882-889.
38. Apple FS, Murakami MM, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945.
39. Pianta TJ, Horvath AR, Ellis VM, Leonetti R, Moffat C, Josland EA, Brown MA: Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients. Nephrology (Carlton) 2012; 17: 636-641.
40. Pianta TJ, Horvath AR, Ellis VM, Leonetti R, Moffat C, Josland EA, Brown MA: Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients. Nephrology (Carlton) 2012; 17: 636-641.
41. Wizermann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574-1579.